Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
Pharma
Lilly's tirzepatide does gangbusters at market and in the clinic
Locked in a heated battled with Novo Nordisk’s semaglutide franchise, Eli Lilly’s tirzepatide is beginning to come into its own.
Fraiser Kansteiner
Feb 6, 2024 9:13am
No evidence of suicidal risk with Novo, Lilly GLP-1s, FDA says
Jan 12, 2024 10:26am
JPM24: In obesity field, Novo is 'just getting going,' CEO says
Jan 10, 2024 11:45am
NFL kicks off ‘My Cause My Cleats’ with a focus on diabetes
Dec 27, 2023 10:49am
Novo Nordisk to reduce supply of Victoza to make more Ozempic
Nov 22, 2023 10:55am
Dexcom Warriors unite for push to help the world #SeeDiabetes
Nov 15, 2023 7:40am